BRPI1005950A2 - aplicação de agentes sensibilizantes de insulina vaginais - Google Patents
aplicação de agentes sensibilizantes de insulina vaginaisInfo
- Publication number
- BRPI1005950A2 BRPI1005950A2 BRPI1005950A BRPI1005950A BRPI1005950A2 BR PI1005950 A2 BRPI1005950 A2 BR PI1005950A2 BR PI1005950 A BRPI1005950 A BR PI1005950A BR PI1005950 A BRPI1005950 A BR PI1005950A BR PI1005950 A2 BRPI1005950 A2 BR PI1005950A2
- Authority
- BR
- Brazil
- Prior art keywords
- vaginal
- application
- sensitizing agents
- insulin sensitizing
- insulin
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 230000001235 sensitizing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200900448A ES2344183B1 (es) | 2009-02-18 | 2009-02-18 | Uso de agentes sensibilizantes a insulina por via vaginal. |
| PCT/ES2010/000067 WO2010094821A1 (es) | 2009-02-18 | 2010-02-16 | Uso de agentes sensibilizantes a insulina por vía vaginal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1005950A2 true BRPI1005950A2 (pt) | 2016-02-10 |
Family
ID=42537373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1005950A BRPI1005950A2 (pt) | 2009-02-18 | 2010-02-16 | aplicação de agentes sensibilizantes de insulina vaginais |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120004271A1 (pt) |
| EP (1) | EP2399583B1 (pt) |
| BR (1) | BRPI1005950A2 (pt) |
| CY (1) | CY1117425T1 (pt) |
| DK (1) | DK2399583T3 (pt) |
| ES (2) | ES2344183B1 (pt) |
| HR (1) | HRP20160280T1 (pt) |
| HU (1) | HUE027369T2 (pt) |
| PL (1) | PL2399583T3 (pt) |
| RU (1) | RU2567334C2 (pt) |
| SI (1) | SI2399583T1 (pt) |
| SM (1) | SMT201600101B (pt) |
| WO (1) | WO2010094821A1 (pt) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478852C1 (en) * | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
| US5874454A (en) * | 1993-09-15 | 1999-02-23 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| FR2774591B1 (fr) * | 1998-02-12 | 2000-05-05 | Lipha | Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie |
| US6100300A (en) * | 1998-04-28 | 2000-08-08 | Bristol-Myers Squibb Company | Metformin formulations and method for treating intermittent claudication employing same |
| RU2201225C2 (ru) * | 1999-04-06 | 2003-03-27 | Зыкова Татьяна Алексеевна | Способ лечения хронической ановуляции и профилактики синдрома гиперстимуляции яичников |
| US7105489B2 (en) * | 2002-01-22 | 2006-09-12 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treating polycystic ovary syndrome |
| MXPA04007713A (es) * | 2002-02-07 | 2004-11-10 | Pfizer | Uso de inhibidores de la fosfodiesterasa tipo 5, tal como sildenafil, en el tratamiento del sindrome de ovario poliquistico. |
| WO2003068209A1 (en) * | 2002-02-14 | 2003-08-21 | Sonus Pharmaceuticals, Inc. | Metformin salts of lipophilic acids |
-
2009
- 2009-02-18 ES ES200900448A patent/ES2344183B1/es active Active
-
2010
- 2010-02-16 US US13/201,991 patent/US20120004271A1/en not_active Abandoned
- 2010-02-16 BR BRPI1005950A patent/BRPI1005950A2/pt not_active Application Discontinuation
- 2010-02-16 EP EP10743433.4A patent/EP2399583B1/en active Active
- 2010-02-16 ES ES10743433.4T patent/ES2569538T3/es active Active
- 2010-02-16 SI SI201031169A patent/SI2399583T1/sl unknown
- 2010-02-16 RU RU2011135702/15A patent/RU2567334C2/ru active
- 2010-02-16 WO PCT/ES2010/000067 patent/WO2010094821A1/es active Application Filing
- 2010-02-16 DK DK10743433.4T patent/DK2399583T3/en active
- 2010-02-16 PL PL10743433.4T patent/PL2399583T3/pl unknown
- 2010-02-16 HU HUE10743433A patent/HUE027369T2/hu unknown
-
2016
- 2016-03-18 HR HRP20160280TT patent/HRP20160280T1/hr unknown
- 2016-04-11 CY CY20161100287T patent/CY1117425T1/el unknown
- 2016-04-12 SM SM201600101T patent/SMT201600101B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20160280T1 (hr) | 2016-06-17 |
| EP2399583B1 (en) | 2016-01-27 |
| ES2344183A1 (es) | 2010-08-19 |
| PL2399583T3 (pl) | 2016-09-30 |
| ES2569538T3 (es) | 2016-05-11 |
| HUE027369T2 (hu) | 2016-09-28 |
| WO2010094821A1 (es) | 2010-08-26 |
| EP2399583A1 (en) | 2011-12-28 |
| ES2344183B1 (es) | 2011-06-10 |
| US20120004271A1 (en) | 2012-01-05 |
| SMT201600101B (it) | 2016-07-01 |
| RU2567334C2 (ru) | 2015-11-10 |
| RU2011135702A (ru) | 2013-03-27 |
| EP2399583A4 (en) | 2012-08-15 |
| DK2399583T3 (en) | 2016-04-18 |
| SI2399583T1 (sl) | 2016-06-30 |
| CY1117425T1 (el) | 2017-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600075B (it) | Composto di diamminocarbossammide eterociclica | |
| FR2956314B1 (fr) | Orthese compressive tubulaire | |
| BRPI1014272A2 (pt) | nova formulação de diclofenac | |
| BRPI1008744A2 (pt) | hidrotratamento de caboidratos | |
| BRPI1014688A2 (pt) | aplicações terapêuticas de derivados de quinazolinadiona | |
| DE112009000964A5 (de) | Tampon | |
| DK2593060T3 (da) | Engangsble | |
| SMT201600031B (it) | Composti eterociclici di fenossimetile | |
| UY33111A (es) | Jeringas | |
| BRPI1006504A2 (pt) | fralda descartavel | |
| SMT201500268B (it) | Derivato di 5-idrossipirimidin-4-carbossammide | |
| DK2453858T3 (da) | Fremgangsmåde | |
| DK2501381T3 (da) | Behandling af atrieflimmer | |
| FI20096402A0 (fi) | Veriryhmästatuksen käyttö II | |
| CU23884B1 (es) | Derivados de dibenzotiazepina | |
| SMT201500123B (it) | Dosaggio unitario di apadenoson | |
| BR112012000079A2 (pt) | derivados fluorados de 3-hidroxipiridin-4-onas | |
| FI20095315A (fi) | Iskulaite | |
| BRPI1005950A2 (pt) | aplicação de agentes sensibilizantes de insulina vaginais | |
| BR112013014456A2 (pt) | dosagens de derivados de arilsulfonamidas | |
| BR112013014710A2 (pt) | entrega de compostos funcionais | |
| FR2955136B1 (fr) | Arret de vantail | |
| UY33133A (es) | Nuevos derivados de piridazina | |
| FI20095316A (fi) | Iskulaite | |
| BR112012013671A2 (pt) | derivados halogenados de fty720 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |